Fresenius

Healthcare

Germany’s Fresenius Beats Q3 Estimates, Raises Full-Year Outlook

Edward Cooke / 6 November 2024

On Wednesday, Fresenius raised its full-year outlook after beating third-quarter expectations, citing strong performances at its Kabi and Helios divisions […]

Germany’s Fresenius Beats Q3 Estimates, Raises Full-Year Outlook Read More »

Healthcare

Fresenius (NYSE: FMS) Looking to Boost Output After Hurricane Damage at Rival Baxter

Zabih Ullah / 8 October 2024

FRANKFURT – Fresenius (NYSE: FMS) said it was checking options to speed up the start of new production lines of

Fresenius (NYSE: FMS) Looking to Boost Output After Hurricane Damage at Rival Baxter Read More »

US Markets

Fresenius (NYSE: FMS) Beats Q2 Profit Estimates, Thanks to Strong Unit Performance and Cost Savings

Maria Reed / 31 July 2024

German healthcare group Fresenius (NYSE: FMS) beat second-quarter operating profit expectations on Wednesday, citing strong performance at its Kabi and

Fresenius (NYSE: FMS) Beats Q2 Profit Estimates, Thanks to Strong Unit Performance and Cost Savings Read More »

Germany’s Fresenius Beats Q3 Estimates, Raises Full-Year Outlook

Fresenius (NYSE: FMS) Looking to Boost Output After Hurricane Damage at Rival Baxter

Fresenius (NYSE: FMS) Beats Q2 Profit Estimates, Thanks to Strong Unit Performance and Cost Savings

Company

About Us

Team

Contact Us

Categories

US Market

Business

Technology

News

Featured

Press Release

Legal

Privacy Policy

Disclaimer